Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2011
Home
2011
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Cellmid Signs Antibody Humanisation Collaboration
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Appendix 3B
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Appendix 4C – quarterly
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Celera license update
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Change of Director’s Interest Notice
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Appendix 3B
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Appendix 4C
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Completed GMP Manufacture of Midkine Test
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Change of Director’s Interest Notice
Prev page
1
2
3
4
5
Next page
